Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Mar 3, 2026 · Filed Mar 4, 2026
Cushman & Wakefield's See Remarks sold $135K of Cushman & Wakefield shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$135,000
Shares × reported transaction price
12 days after results of Feb 19, 2026, 65 days before results of May 7, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −10.3% | −2.2% | −8.0% |
| 30 days | −4.8% | −3.3% | −1.5% |
| 90 days | −4.5% | +10.7% | −15.2% |
| 180 days | +1.1% | +11.8% | −10.8% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Compensation award — excluded from discretionary-purchase analysis.